1.
Bernhard JD, Pathak MA, Kocher IE, Parrish JA: Abnormal reactions to ultraviolet radiation; in Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds): Dermatology in General Medicine, ed 5. New York, McGraw-Hill, 1999, pp 1578–1579.
2.
Santoianni P: Orticaria solare; in Santoianni P (ed): Fotodermatologia. Roma, Il Pensiero Scientifico, 1993, pp 63–68.
3.
Harber LC, Holloway RM, Wheatley VR, Baer RL: Immunologic and biophysical studies in solar urticaria. J Invest Dermatol 1963;41:439–443.
4.
Ive H, Lloyd J, Magnus IA: Action spectra in idiopathic solar urticaria: A study of 17 cases with a monochromator. Br J Dermatol 1965;77:229–243.
5.
Ravits M, Armstrong RB, Harber L: Solar urticaria: Clinical features and wavelength dependence. Arch Dermatol 1982;118:228–231.
6.
Parrish JA, Jaenicke KF, Morrison WL, Momtaz TK, Shea C: Solar urticaria: Treatment with PUVA and mediator inhibitors. Br J Dermatol 1982;106:575–580.
7.
Urso B, D’Alto V, Perrelli P, Monfrecola G: La fotoprotezione per via topica. Quad Med Chir 1992;8:3–5.
8.
Kobza Black A, Ramsay CA, Magnus IA: Oral β-carotene therapy in actinic reticuloid and solar urticaria: Failure to demonstrate a photoprotective effect against long-wave UV and visible radiation. Br J Dermatol 1973;88:157–166.
9.
Sams WM Jr: Chloroquine: Its use in photosensitive eruptions. Int J Dermatol 1976;15:99–111.
10.
Monfrecola G, Pini D, Urso B: Orticaria solare: approccio diagnostico e terapeutico. Chron Dermatol 1989;20:183–186.
11.
Bernhard JD, Jaenicke KF, Momtaz TK, Parrish JA: Ultraviolet A phototherapy in the prophylaxis of solar urticaria. J Am Acad Dermatol 1984;10:29–33.
12.
Ferguson J, Addo HA: Solar urticaria treated with PUVA. Br J Dermatol 1982;107(suppl 13):59–60.
13.
Juhlin L, Malmros-Enander I: Solar urticaria: Mechanism and treatment. Photodermatology 1986;3:164–168.
14.
Duscet P, Leyen P, Schwarz T, Hocker P, Greiter J, Gshnait F: Solar urticaria: Treatment by plasmapheresis. J Am Acad Dermatol 1986;15:712–713.
15.
Marone G: Milestones in the biology and pharmacology of histamine H1-receptor antagonist. Allergy 1997;52(suppl 34):7–13.
16.
Diffey BL, Farr PM: Treatment of solar urticaria with terfenadine. Photodermatology 1988;5:25–29.
17.
Monfrecola G, Nappa P, Pini D: Solar urticaria in the visible spectrum successfully treated with astemizole. Dermatologica 1990;180:154–156.
18.
Breneman D, Bronsky EA, Bruce S, Kalivas JT, Klein GL, Roth HL, Tharp MD, Treger C, Soter N: Cetirizine and astemizole therapy for chronic idiopathic urticaria: A double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol 1995;33:192–198.
19.
Bilsland D, Ferguson J: A comparison of cetirizine and terfenadine in the management of solar urticaria. Photodermatol Photoimmunol Photomed 1991;8:62–64.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.